Sivan Subburaju

5PUBLICATIONS
20CO-AUTHORS
Biologically active moleculesCellular nervous systemMolecular medicineMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 08, 2026
Characterization of [<sup>3</sup>H]MCL-524, a Potent Dopamine D<sub>2</sub> <sup>high</sup> Receptor Agonist.

|May 23, 2024
Single-cell multi-cohort dissection of the schizophrenia transcriptome.

W Brad Ruzicka, Shahin Mohammadi, John F Fullard

|Apr 12, 2021
The High Affinity Dopamine D<sub>2</sub> Receptor Agonist MCL-536: A New Tool for Studying Dopaminergic Contribution to Neurological Disorders.

Sivan Subburaju, Anna W Sromek, Philip Seeman

|Oct 10, 2020
NAD<sup>+</sup>-mediated rescue of prenatal forebrain angiogenesis restores postnatal behavior.

Sivan Subburaju, Sarah Kaye, Yong Kee Choi

|Apr 12, 2018
New Dopamine D2 Receptor Agonist, [<sup>3</sup>H]MCL-536, for Detecting Dopamine D2high Receptors in Vivo.

Sivan Subburaju, Anna W Sromek, Philip Seeman

Pageof 1

Frequent Collaborators

2 joint publications

John L Neumeyer

1 joint publications

Yong Kee Choi

1 joint publications

Jugajyoti Baruah

1 joint publications

Jun Ren